bioRxivBioinformaticsPreprint
Genomic analyses identify significant molecules and biological processes in colorectal cancer cells with DNA damage
- Citations
- 0
Abstract
Colorectal cancer is a major cause of cancer deaths in the US. DNA damage is considered to be a novel target for the treatment of colorectal cancer. However, the molecular mechanisms and functions are still unclear. In this study, we aim to identify the significant molecules and signaling by analyzing the RNA-seq data. The GSE189366 was created by the BGISEQ-500 (Homo sapiens). The KEGG and GO analyses indicated the p53 signaling pathway and Hippo signaling pathway are major affected processes in colorectal cancer by DNA damage. Furthermore, we identified ten key interactive molecules including CDK1, STAT3, MDM2, CCNB1, CCNA2, CDKN1A, PCNA, AURKA, PLK1, and CDC6. Our study may provide potential drug targets for colorectal cancer.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genomic analyses identify significant biological processes in DDX21-mediated colorectal cancer cells
Xueying Wang, Donghong Zhang, Mengshan Wang·bioRxiv·Apr 28, 2022
- Genomic analyses identify biological processes in ZKSCAN3-deficient colorectal cancer cells
Zhiwen Qian, Tingxiang Chang, … Hanming Gu·bioRxiv·Dec 30, 2021
- Integrative network modeling of colorectal cancer reveals diagnostic signatures and therapeutic targets
Faiz M. Khan, Muhammad Naveez, … Julio Vera·bioRxiv·Aug 18, 2025
- Loss of BCL-3 sensitises colorectal cancer cells to DNA damage, revealing a role for BCL-3 in double strand break repair by homologous recombination
C. Parker, A. C. Chambers, … A. C. Williams·bioRxiv·Aug 3, 2021
- Exploring potential targets for quercetin treatment of colorectal cancer through network pharmacology and molecular docking technology
Yuanyuan Qian, Zhaojunli Wang, … Wenlong Fu·bioRxiv·Jul 29, 2024
- A crypt-operating DNA repair checkpoint for uncoupling regeneration and tumorigenesis
Richard Ruez, K. Radulovic, … Mathias Chamaillard·bioRxiv·Mar 2, 2026